Documento2009.-Weighing Benefits and Risks the FDA's Review of Prasugrelenviado por
tristan9454- Documento2009.Prasugrel in Clinical Practice..enviado portristan9454
- Documento2009.-Prasugrel in Clinical Practiceenviado portristan9454
- Documento2009.- Weighing Benfits and Risk...enviado portristan9454
- Documento2009.- Prasugrel Stemi Subgroup Analysis.autor's Replyenviado portristan9454
- Documento2009.- Prasugrel Stemi Subgroup Analysisenviado portristan9454
- Documento2009.- Effect of the Novel Thienopyridine Prasugrel....enviado portristan9454
- Documento2008.-The Use of the VerifyNow P2Y12 Point-Of-care Device to Monitorenviado portristan9454
- Documento2008.Prasugrel...Acute Coronary Syndromesenviado portristan9454
- Documento2008.-Prasugrel Achieves Greater and Faster P2Y12..enviado portristan9454
- Documento2008.-Bleeding Risks With Pasugre.....enviado portristan9454
- Documento2008. Prasugrel.....Patients With Acute Coronary.enviado portristan9454
- Documento2008. Intensive Anti Platelet ... Prasugrelenviado portristan9454
- Documento2007.-A Comparison of the Anti Platelet Effects of Prasugrel..enviado portristan9454
- Documento2009.- Stroke Prevention in Atrial Fibrillation....enviado portristan9454
- Documento2009.- Cutaneous Blodd Filled Vesicles on Idraparinuxenviado portristan9454
- Documento2009.- Comparison of Idraparinux With Vitamin Kenviado portristan9454
- Documento2007.-High Affinity Interaction Between a Synthetic, Highly Negatively Charged..enviado portristan9454
- Documento2007.-Agents to Control Bleeding Show Promiseenviado portristan9454
- Documento2005.-Reversal of a Potent Investigational Anticoagulant Idraparinux With Recombinant Factor VIIa.enviado portristan9454
- Documento2005.Reversal Investigational Anticoagulan Idraparinux...enviado portristan9454
- Documento2004.Oligosaccharides...enviado portristan9454
- Documento2003.Synthetic Pentasaccharides...enviado portristan9454
- DocumentoShort- And Long-Acting Synthetic Pent a Sac Char Idesenviado portristan9454
- Documento2009.- The Pharmacokinetics of Idraparinux, A Long-Acting Indirect Factor Xa Inhibitor Population Pharmacokinetic Analysis From Phase III Clinical Trials.enviado portristan9454
- Documento2006.-Thrombocytopenia Associated With the Use ...enviado portristan9454
- Documento2006.-Frequency and Management of Thrombocytopenia...enviado portristan9454
- Documento2006.-Abciximab Associated Thrombocytopenia...enviado portristan9454
- Documento2005.-Immune Thrombocytopenia Caused by Glycoprotein....enviado portristan9454
- Documento2004.-Repetitive Profound Thrombocytopenia After Treatment With Tirofiban a Case Report.enviado portristan9454
- Documento2009.-First Report of Tirofiban-Induced Anemia (Found in Combination With Severe Thrombocytopeniaenviado portristan9454
- Documento2002.-Acute Thrombocytopenia After Treatment With Tirofiban or Eptifibatide is a2002.enviado portristan9454
- Documento2006.-Thrombocytopenia Associated With the Use ...enviado portristan9454
- Documento2006.-Frequency and Management of Thrombocytopenia...enviado portristan9454
- Documento2006.-Abciximab Associated Thrombocytopenia...enviado portristan9454
- Documento2005.-Immune Thrombocytopenia Caused by Glycoprotein....enviado portristan9454
- Documento2004.-Repetitive Profound Thrombocytopenia After Treatment With Tirofiban a Case Report.enviado portristan9454
- Documento2002.-Acute Thrombocytopenia After Treatment With Tirofiban or Eptifibatide is a2002.enviado portristan9454
- Documento2009.-First Report of Tirofiban-Induced Anemia (Found in Combination With Severe Thrombocytopeniaenviado portristan9454
- Documento1.-BISTRO Ienviado portristan9454
- Documento1.-BISTRO Ienviado portristan9454
Escolar Documentos
Profissional Documentos
Cultura Documentos
